Бронхиальная астма и воздействие производственных факторов: клинические рекомендации Европейского респираторного общества
Источник: Baur X., Sigsgaard T., Aasen T.B. et al. Guidelines for the management of work)related asthma. Eur. Respir. J. 2012; 39: 529–545.
Об авторестатья Редакционная
1. Bernstein I.L., Chan'Yeung M., Malo J.L. et al. Asthma in the workplace and related conditions. 3rd ed. New York: Taylor & Francis, 2006.
2. Baur X., Aasen T., Burge S. et al. The management of work-related asthma guidelines: a broader perspective. Eur. Respir. Rev. 2012 (in press).
3. Tarlo S.M., Balmes J., Balkissoon R. et al. Diagnosis and management of work-related asthma: American College of Chest Physicians Consensus Statement. Chest 2008; 134: 1S–41S.
4. Davison A.G., Fayers P.M., Taylor A.J. et al. Cadmium fume inhalation and emphysema. Lancet 1988; 1: 663–667.
5. Postma D.S., Boezen H.M. Rationale for the Dutch hypothesis. Allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. Chest 2004; 126: 96S–104S; discuss. 159S–161S.
6. Hargreave F.E., Parameswaran K. Asthma, COPD and bronchitis are just components of airway disease. Eur. Respir. J. 2006; 28: 264–267.
7. Meldrum M., Rawbone R., Curran A.D. et al. The role of occupation in the development of chronic obstructive pulmonary disease (COPD). Occup. Environ. Med. 2005; 62: 212–214.
8. Hnizdo E., Sullivan P.A., Bang K.M. et al. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 2002; 156: 738–746.
9. Christiani D.C. Occupation and COPD. Occup. Environ. Med. 2005; 62: 215.
10. Bergdahl I.A., Toren K., Eriksson K. et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur. Respir. J. 2004; 23: 402–406.
11. Balmes J.R., Nowak D. COPD caused by occupational exposure. In: Donner C.F., Carone M., eds. COPD. Oxford: Clinical Publishing; 2007. 85–95.
12. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1995; 152: 77–121.
13. Davison A.G., Fayers P.M., Taylor A.J. et al. Cadmium fume inhalation and emphysema. Lancet 1988; 1: 663–667.
14. Vandenplas O., Jamart J., Delwiche J.P. et al. Occupational asthma caused by natural rubber latex: outcome according to cessation or reduction of exposure. J. Allergy Clin. Immunol. 2002; 109: 125–130.
15. Vandenplas O., Malo J.L., Pauli G. Hyperreactivite bronchique non allergenique et agents professionnels. Rev. Mal. Respir. 1994; 11: 189–199.
16. Bourdin A., Serre I., Flamme H. et al. Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice? Thorax 2004; 59: 488–493.
17. Hargreave F.E., Nair P. The definition and diagnosis of asthma. Clin. Exp. Allergy 2009; 39: 1652–1658.
18. Anees W., Moore V.C., Burge P.S. FEV1 decline in occupational asthma. Thorax 2006; 61: 751–755.
19. Blanc P.D., Torén K. Occupation in chronic obstructive pulmonary disease and chronic bronchitis: an update. Int. J. Tuberc. Lung Dis. 2007; 11: 251–257.
20. Salvi S.S., Barnes P.J. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374: 733–743.
21. Behrendt C.E. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 2005; 128: 1239–1244.
22. Lamprecht B., Schirnhofer L., Kaiser B. et al. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study. Am. J. Industr. Med. 2007; 50: 421–426.
23. Ulvestad B., Bakke B., Eduard W. et al. Cumulative exposure to dust causes accelerated decline in lung function in tunnel workers. Occup. Environ. Med. 2001; 58: 663–669.
24. Weinmann S., Vollmer W.M., Breen V. et al. COPD and occupational exposures: a case-control study. J. Occup. Environ. Med. 2008; 50: 561–569.
25. Newman Taylor A.J., Cullinan P. et al. BOHRF guidelines for occupational asthma. Thorax 2005; 60: 364–366.
26. Beach J., Rowe B.H., Blitz S. et al. Diagnosis and management of work-related asthma. Evidence report / technology assessment no 129. US Department of Health and Human Services, Agency for Healthcare Research and Quality. www.ahrq.gov/downloads/pub/evidence/pdf/asth'mawork/ asthwork.pdf Date last updated: November 2005. Date last accessed January 16, 2012.
27. Mannino D.M. How much asthma is occupationally related? Occup. Med. 2000; 15: 359–368.
28. Balmes J., Becklake M., Blanc P. et al. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am. J. Respir. Crit. Care Med. 2003; 167: 787–797.
29. Kogevinas M., Zock J.P., Jarvis D. et al. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 2007; 370: 336–341.
30. Latza U., Baur X. Occupational obstructive airway diseases in Germany: frequency and causes in an international comparison. Am. J. Industr. Med. 2005; 48: 144–152.
31. Boyd R., Cowie H., Hurley F. et al. The true cost of occupational asthma in Great Britain. Research Report 474. Suffolk: Health & Safety Executive (HSE); 2006.
32. Harbour R., Miller J. A new system for grading recommendations in evidence based guidelines. Br. Med. J. 2001; 323: 334–336.
33. Vlaanderen J., Vermeulen R., Heederik D. et al. Guidelines to evaluate human observational studies for quantitative risk assessment. Environ. Hlth Perspect. 2008; 116: 1700–1705.
34. Lenters V., Vermeulen R., Dogger S. et al. A meta-analysis of asbestos and lung cancer: is better quality exposure assessment associated with steeper slopes of the exposureresponse relationships? Environ. Hlth Perspect. 2011; 119: 1547–1555.
35. Vandenplas O., Dressel H., Wilken D. et al. Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence. Eur. Respir. J. 2011; 38: 804–811.
36. The Royal College of General Practitioners. The development and implementation of clinical guidelines. Report of the Clinical Guidelines Working Group. London, RCGP, 1995.
37. Atkins D., Best D., Briss P.A. et al. Grading quality of evidence and strength of recommendations. Br. Med. J. 2004; 328: 1490.
38. Schunemann H.J., Jaeschke R., Cook D.J. et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am. J. Respir. Crit. Care Med. 2006; 174: 605–614.
39. Baur X., Huber H., Degens P.O. et al. Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am. J. Industr. Med. 1998; 33: 114–122.
40. Cote J., Kennedy S., Chan'Yeung M. Quantitative versus qualitative analysis of peak expiratory flow in occupational asthma. Thorax 1993; 48: 48–51.
41. Malo J.L., Ghezzo H., L’Archeveque J. et al. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am. Rev. Respir. Dis. 1991; 143: 528–532.
42. Merget R., Schultze'Werninghaus G., Muthorst T. et al. Asthma due to the complex salts of platinum – a crosssectional survey of workers in a platinum refinery. Clin. Allergy 1988; 18: 569–580.
43. Vandenplas O., Delwiche J.P., Evrard G. et al. Prevalence of occupational asthma due to latex among hospital personnel. Am. J. Respir. Crit. Care Med. 1995; 151: 54–60.
44. Vandenplas O., Binard'Van Cangh F., Brumagne A. et al. Occupational asthma in symptomatic workers exposed to natural rubber latex: evaluation of diagnostic procedures. J. Allergy Clin. Immunol. 2001; 107: 542–547.
45. Vandenplas O., Ghezzo H., Munoz X. et al. What are the questionnaire items most useful in identifying subjects with occupational asthma? Eur. Respir. J. 2005; 26: 1056–1063.
46. Nicholson P.J., Cullinan P., Burge P.S. et al., eds. Occupational asthma: Prevention, identification and management: Systematic review & recommendations. London; British Occupational Health Research Foundation; 2010.
47. Nicholson P.J., Cullinan P., Taylor A.J. et al. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup. Environ. Med. 2005; 62: 290–299.
48. Moore V.C., Jaakkola M., Burge P. A systematic review of serial peak expiratory flow measurements in the diagnosis of occupational asthma. Ann. Respir. Med. 2010; 1: 31–44.
49. Burge P.S., O’Brien I.M., Harries M.G. Peak flow rate records in the diagnosis of occupational asthma due to colophony. Thorax 1979; 34: 308–316.
50. Burge P.S., O’Brien I.M., Harries M.G. Peak flow rate records in the diagnosis of occupational asthma due to isocyanates. Thorax 1979; 34: 317–323.
51. Park D., Moore V.C., Burge C.B. et al. Serial PEF measurement is superior to cross-shift change in diagnosing occupational asthma. Eur. Respir. J. 2009; 34: 574–578.
52. Cote J., Kennedy S., Chan'Yeung M. Sensitivity and specificity of PC20 and peak expiratory flow rate in cedar asthma. J. Allergy Clin. Immunol. 1990; 85: 592–598.
53. Perrin B., Lagier F., L’Archeveque J. et al. Occupational asthma: validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur. Respir. J. 1992; 5: 40–48.
54. Tarlo S.M., Broder I. Outcome of assessments for occupational asthma. Chest 1991; 100: 329–335.
55. Girard F., Chaboillez S., Cartier A. et al. An effective strategy for diagnosing occupational asthma: use of induced sputum. Am. J. Respir. Crit. Care Med. 2004; 170: 845–850.
56. Baur X., Czuppon A. Diagnostic validation of specific IgE antibody concentrations, skin prick testing, and challenge tests in chemical workers with symptoms of sensitivity to different anhydrides. J. Allergy Clin. Immunol. 1995; 96: 489–494.
57. Platts'Mills T.A., Longbottom J., Edwards J. et al. Occupational asthma and rhinitis related to laboratory rats: serum IgG and IgE antibodies to the rat urinary allergen. J. Allergy Clin. Immunol. 1987; 79: 505–515.
58. Grammer L., Shaughnessy M., Kenamore B. Utility of antibody in identifying individuals who have or will develop anhydrideinduced respiratory disease. Chest 1998; 114: 1199–1202.
59. Howe W., Venables K.M., Topping M.D. et al. Tetrachlorophthalic anhydride asthma: evidence for specific IgE antibody. J. Allergy Clin. Immunol. 1983; 71: 5–11.
60. Park H.S., Kim Y.J., Lee M.K. et al. Occupational asthma and IgE antibodies to reactive dyes. Yonsei Med. J. 1989; 30: 298–304.
61. Park J.W., Kim C.W., Kim K.S. et al. Role of skin prick test and serological measurement of specific IgE in the diagnosis of occupational asthma resulting from exposure to vinyl sulphone reactive dyes. Occup. Environ. Med. 2001; 58: 411–416.
62. Baur X., Barbinova L. Increase of exhaled nitric oxide (eNO) after methylene diphenyl diisocyanate (MDI) exposure in isocyanate workers with bronchial hyperresponsiveness. Allergol. Int. 2005; 54: 151–158.
63. Cartier A., Grammer L., Malo J.L. et al. Specific serum antibodies against isocyanates: association with occupational asthma. J. Allergy Clin. Immunol. 1989; 84: 507–514.
64. Lin F.J., Chen H., Chan'Yeung M. New method for an occupational dust challenge test. Occup. Environ. Med. 1995; 52: 54–56.
65. Moscato G., Dellabianca A., Vinci G. et al. Toluene diisocyanateinduced asthma: clinical findings and bronchial responsiveness studies in 113 exposed subjects with workrelated respiratory symptoms. J. Occup. Med.1991; 33: 720–725.
66. Munoz X., Cruz M.J., Orriols R. et al. Validation of specific inhalation challenge for the diagnosis of occupational asthma due to persulphate salts. Occup. Environ. Med. 2004; 61: 861–866.
67. Rioux J.P., Malo J.L., L’Archeveque J. et al. Workplacespecific challenges as a contribution to the diagnosis of occupational asthma. Eur. Respir. J. 2008; 32: 997–1003.
68. Alvarez M.J., Estrada J.L., Gozalo F. et al. Oilseed rape flour: another allergen causing occupational asthma among farmers. Allergy 2001; 56: 185–188.
69. Krakowiak A., Krawczyk'Adamus P., Dudek W. et al. Changes in cellular and biochemical profiles of induced sputum after allergen-induced asthmatic response: method for studying occupational allergic airway inflammation. Int. J. Occup. Med. Environ. Hlth 2005; 18: 27–33.
70. Lemiere C., Chaboillez S., Malo J.L. et al. Changes in sputum cell counts after exposure to occupational agents: what do they mean? J. Allergy Clin. Immunol. 2001; 107: 1063–1068.
71. Maestrelli P., Calcagni P.G., Saetta M. et al. Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects. Clin. Exp. Allergy 1994; 24: 29–34.
72. Obata H., Dittrick M., Chan H. et al. Sputum eosinophils and exhaled nitric oxide during late asthmatic reaction in patients with western red cedar asthma. Eur. Respir. J. 1999; 13: 489–495.
73. Baur X., Barbinova L. Latex allergen exposure increases exhaled nitric oxide in symptomatic healthcare workers. Eur. Respir. J. 2005; 25: 309–316.
74. Piipari R., Piirila P., Keskinen H. et al. Exhaled nitric oxide in specific challenge tests to assess occupational asthma. Eur. Respir. J. 2002; 20: 1532–1537.
75. Barbinova L., Baur X. Increase in exhaled nitric oxide (eNO) after work-related isocyanate exposure. Int. Arch. Occup. Environ. Hlth 2006; 79: 387–395.
76. Malo J.L., Chan'Yeung M. Agents causing occupational asthma with key references. In: Bernstein I.L., Chan-Yeung M., Malo J.L. et al., eds. Asthma in the workplace. 3rd ed. New York: Taylor & Francis Group; 2006.
77. Baur X. Airborne allergens and irritants in the workplace. In: Kay A.B., Kaplan A.P., Bousquet J. et al, eds. Allergy and allergic diseases. Oxford: Blackwell Publishing; 2008. 1017–1122.
78. Stenton S.C., Avery A.J., Walters E.H. et al. Statistical approaches to the identification of late asthmatic reactions. Eur. Respir. J. 1994; 7: 806–812.
79. Maestrelli P., Schlünssen V., Mason P. et al. Contribution of host factors and workplace exposure to the outcome of occupational asthma. Eur. Respir. Rev. 2012 (in press).
80. Vandenplas O., Dressel H., Wilken D. et al. Management of occupational asthma: cessation or reduction of exposure? Eur. Respir. J. 2011; 38: 804-811.
81. Tarlo S.M., Banks D., Liss G. et al. Outcome determinants for isocyanate induced occupational asthma among compensation claimants. Occup. Environ. Med. 1997; 54: 756–761.
82. Chan'Yeung M., MacLean L., Paggiaro P.L. Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata). J. Allergy Clin. Immunol. 1987; 79: 792–796.
83. Rosenberg N., Garnier R., Rousselin X. et al. Clinical and socioprofessional fate of isocyanate-induced asthma. Clin. Allergy 1987; 17: 55–61.
84. Moscato G., Bertoletti R., Biscaldi G. et al. Occupational asthma: fate and management after the diagnosis. G. Ital. Med. Lav. 1993; 15: 27–31.
85. Gannon P.F., Weir D.C., Robertson A.S. et al. Health, employment, and financial outcomes in workers with occupational asthma. Br. J. Industr. Med. 1993; 50: 491–496.
86. Orriols R., Drobnic M.E., Munoz X. et al. Asma ocupacional por isocianatos: estudio de 21 pacientes [Occupational asthma due to isocyanates: a study of 21 patients]. Med. Clin. (Barc.) 1999; 113: 659–662.
87. Merget R., Schulte A., Gebler A. et al. Outcome of occupational asthma due to platinum salts after transferral to lowexposure areas. Int. Arch. Occup. Environ. Hlth 1999; 72: 33–39.
88. Valentino M., Rapisarda V. Evoluzione dell’asma da isocianati in rapporto alla cessazione dell’esposizione: studio longitudinale su 50 soggetti. G. Ital. Med. Lav. Ergon. 2002; 24: 26–31.
89. Padoan M., Pozzato V., Simoni M. et al. Long-term followup of toluene diisocyanate-induced asthma. Eur. Respir. J. 2003; 21: 637–640.
90. Lin F.J., Dimich'Ward H., Chan'Yeung M. Longitudinal decline in lung function in patients with occupational asthma due to western red cedar. Occup. Environ. Med. 1996; 53: 753–756.
91. Marabini A., Siracusa A., Stopponi R. et al. Outcome of occupational asthma in patients with continuous exposure: a 3-year longitudinal study during pharmacologic treatment. Chest 2003; 124: 2372–2376.
92. Perez P.A., Bueso F.A., Garcia L.J. et al. Effect of omalizumab treatment in a baker with occupational asthma. J. Invest. Allergol. Clin. Immunol. 2008; 18: 490–491.
93. Olivieri M., Biscardo C.A., Turri S. et al. Omalizumab in persistent severe bakers’ asthma. Allergy 2008; 63: 790–791.
94. Sastre J., Quirce S. Immunotherapy: an option in the management of occupational asthma? Curr. Opin. Allergy Clin. Immunol. 2006; 6: 96–100.
95. Rachiotis G., Savani R., Brant A. et al. Outcome of occupational asthma after cessation of exposure: a systematic review. Thorax 2007; 62: 147–152.
96. Pisati G., Baruffini A., Bernabeo F. et al. Rechallenging subjects with occupational asthma due to toluene diisocyanate (TDI), after long-term removal from exposure. Int. Arch. Occup. Environ. Hlth 2007; 80: 298–305.
97. Brant A., Zekveld C., Welch J. et al. The prognosis of occupational asthma due to detergent enzymes: clinical, immunological and employment outcomes. Clin. Exp. Allergy 2006; 36: 483–488.
98. Klusackova P., Pelclova D., Jindriska Levedova D. et al. Occupational asthma after withdrawal from the occupational allergen exposure. Industr. Hlth 2006; 44: 629–638.
99. Labrecque M., Khemici E., Cartier A. et al. Impairment in workers with isocyanate-induced occupational asthma and removed from exposure in the province of Quebec between 1985 and 2002. J. Occup. Environ. Med. 2006; 48: 1093–1098.
100. Park H.W., Kim D.I., Sohn S.W. et al. Outcomes in occupational asthma caused by reactive dye after long-term avoidance. Clin. Exp. Allergy 2007; 37: 225–230.
101. Park J.W., Yang J.Y., Kim C.W. et al. Avoidance therapy in reactive dye-induced occupational asthma: long-term follow-up. Ann. Allergy Asthma Immunol. 2006; 97: 551–556.
102. Yacoub M.R., Lavoie K., Lacoste G. et al. Assessment of impairment / disability due to occupational asthma through a multidimensional approach. Eur. Respir. J. 2007; 29: 889–896.
103. Munoz X., Gomez'Olles S., Cruz M.J. et al. Evolucion de la hiperrespuesta bronquial en pacientes con asma ocupacional por exposicion a sales de persulfato [Course of bronchial hyperresponsiveness in patients with occupational asthma caused by exposure to persulfate salts]. Arch. Bronconeumol. 2008; 44: 140–145.
104. Malo J.L., Ghezzo H. Recovery of methacholine responsiveness after end of exposure in occupational asthma. Am. J. Respir. Crit. Care Med. 2004; 169: 1304–1307.
105. Maghni K., Lemiere C., Ghezzo H. et al. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am. J. Respir. Crit. Care Med. 2004; 169: 367–372.
106. Piirila P.L., Meuronen A., Majuri M.L. et al. Inflammation and functional outcome in diisocyanate-induced asthma after cessation of exposure. Allergy 2008; 63: 583–591.
107. Sumi Y., Foley S., Daigle S. et al. Structural changes and airway remodelling in occupational asthma at a mean interval of 14 years after cessation of exposure. Clin. Exp. Allergy 2007; 37: 1781–1787.
108. Maestrelli P., De Marzo N., Saetta M. et al. Effects of inhaled beclomethasone on airway responsiveness in occupational asthma. Placebo-controlled study of subjects sensitized to toluene diisocyanate. Am. Rev. Respir. Dis. 1993; 148: 407–412.
109. Malo J.L., Cartier A., Cote J. et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. Am. J. Respir. Crit. Care Med. 1996; 153: 953–960.
110. GINA. Global strategy for asthma management and prevention. NIH publication. Bethesda, Global Initiative for Asthma, National Institute of Health, National Heart, Lung and Blood Institute, 2004. Report № 02–3659.
111. Halbert R.J., Tinkelman D.G., Globe D.R. et al. Measuring asthma control is the first step to patient management: a literature review. J. Asthma 2009; 46: 659–664.
112. Pisati G., Baruffini A., Zedda S. Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure. Br. J. Industr. Med. 1993; 50: 60–64.
113. Burge P.S. Occupational asthma in electronics workers caused by colophony fumes: follow-up of affected workers. Thorax 1982; 37: 348–353.
114. Paggiaro P.L., Vagaggini B., Dente F.L. et al. Bronchial hyperresponsiveness and toluene diisocyanate. Long-term change in sensitized asthmatic subjects. Chest 1993; 103: 1123–1128.
115. Bernstein D.I., Karnani R., Biagini R.E. et al. Clinical and occupational outcomes in health care workers with natural rubber latex allergy. Ann. Allergy Asthma Immunol. 2003; 90: 209–213.
116. Slovak A.J., Orr R.G., Teasdale E.L. Efficacy of the helmet respirator in occupational asthma due to laboratory animal allergy (LAA). Am. Industr. Hyg. Assoc. J. 1985; 46: 411–415.
117. Taivainen A.I., Tukiainen H.O., Terho E.O. et al. Powered dust respirator helmets in the prevention of occupational asthma among farmers. Scand. J. Work Environ. Hlth 1998; 24: 503–507.
118. Laoprasert N., Swanson M.C., Jones R.T. et al. Inhalation challenge testing of latex-sensitive health care workers and the effectiveness of laminar flow HEPA-filtered helmets in reducing rhinoconjunctival and asthmatic reactions. J. Allergy Clin. Immunol. 1998; 102: 998–1004.
119. Muller'Wening D., Neuhauss M. Protective effect of respiratory devices in farmers with occupational asthma. Eur. Respir. J. 1998; 12: 569–572.
120. Kongerud J., Rambjor O. The influence of the helmet respirator on peak flow rate in aluminum potroom. Am. Industr. Hyg. Assoc. J. 1991; 52: 243–248.
121. Cote J., Kennedy S., Chan'Yeung M. Outcome of patients with cedar asthma with continuous exposure. Am. Rev. Respir. Dis. 1990; 141: 373–376.
122. Wilken D., Baur X., Barbinova L. et al. What are the benefits of medical screening and surveillance? Eur. Respir. Rev. 2012 (in press).
123. Bryant D.H., Boscato L.M., Mboloi P.N. et al. Allergy to laboratory animals among animal handlers. Med. J. Aust. 1995; 163: 415–418.
124. Venables K.M., Tee R.D., Hawkins E.R. et al. Laboratory animal allergy in a pharmaceutical company. Br. J. Industr. Med. 1988; 45: 660–666.
125. Kim Y.K., Son J.W., Kim H.Y. et al. Citrus red mite (Panonychus citri) is the most common sensitizing allergen of asthma and rhinitis in citrus farmers. Clin. Exp. Allergy 1999; 29: 1102–1109.
126. Skjold T., Dahl R., Juhl B. et al. The incidence of respiratory symptoms and sensitisation in baker apprentices. Eur. Respir. J. 2008; 32: 452–459.
127. Walusiak J., Hanke W., Gorski P. et al. Respiratory allergy in apprentice bakers: do occupational allergies follow the allergic march? Allergy 2004; 59: 442–450.
128. Portengen L., Hollander A., Doekes G. et al. Lung function decline in laboratory animal workers: the role of sensitisation and exposure. Occup. Environ. Med. 2003; 60: 870–875.
129. Renstrom A., Malmberg P., Larsson K. et al. Prospective study of laboratory-animal allergy: factors predisposing to sensitization and development of allergic symptoms. Allergy 1994; 49: 548–552.
130. Agrup G., Belin L., Sjostedt L. et al. Allergy to laboratory animals in laboratory technicians and animal keepers. Br. J. Industr. Med. 1986; 43: 192–198.
131. Baur X., Konig G., Bencze K. et al. Clinical symptoms and results of skin test., RAST and bronchial provocation test in thirty-three papain workers: evidence for strong immunogenic potency and clinically relevant ‘‘proteolytic effects of airborne papain’’. Clin. Allergy 1982; 12: 9–17.
132. Gautrin D., Ghezzo H., Infante'Rivard C. et al. Natural history of sensitization., symptoms and occupational diseases in apprentices exposed to laboratory animals. Eur. Respir. J. 2001; 17: 904–908.
133. Cockcroft A., Edwards J., McCarthy P. et al. Allergy in laboratory animal workers. Lancet 1981; 1: 827–830.
134. Juniper C.P., Roberts D.M. Enzyme asthma: fourteen years’ clinical experience of a recently prescribed disease. J. Soc. Occup. Med. 1984; 34: 127–132.
135. De Zotti R., Bovenzi M. Prospective study of work related respiratory symptoms in trainee bakers. Occup. Environ. Med. 2000; 57: 58–61.
136. Slovak A.J., Hill R.N. Does atopy have any predictive value for laboratory animal allergy? A comparison of different concepts of atopy. Br. J. Industr. Med. 1987; 44: 129–132.
137. Suarthana E. Predicting occupational lung diseases. PhD thesis. Utrecht: Utrecht University; 2008. 127.
138. Meijer E., Grobbee D.E., Heederik D. A strategy for health surveillance in laboratory animal workers exposed to high molecular weight allergens. Occup. Environ. Med. 2004; 61: 831–837.
139. Suarthana E., Meijer E., Grobbee D.E. et al. Predicting occupational diseases. Occup. Environ. Med. 2009; 66: 713–714.
140. Gautrin D., Ghezzo H., Infante'Rivard C. et al. Long-term outcomes in a prospective cohort of apprentices exposed to high-molecularweight agents. Am. J. Respir. Crit. Care Med. 2008; 177: 871–879.
141. Gautrin D., Infante'Rivard C., Ghezzo H. et al. Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am. J. Respir. Crit. Care Med. 2001; 163: 899–904.
142. Mapp C.E., Dal Vecchio L., Boschetto P. et al. Toluene diisocyanate-induced asthma without airway hyperresponsiveness. Eur. J. Respir. Dis. 1986; 68: 89–95.
143. Schumacher M.J., Tait B.D., Holmes M.C. Allergy to murine antigens in a biological research institute. J. Allergy Clin. Immunol. 1981; 68: 310–318.
144. Balboni A., Baricordi O.R., Fabbri L.M. et al. Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57. Eur. Respir. J. 1996; 9: 207–210.
145. Horne C., Quintana P.J., Keown P.A. et al. Distribution of DRB1 and DQB1 HLA class II alleles in occupational asthma due to western red cedar. Eur. Respir. J. 2000; 15: 911–914.
146. Meijer E., Grobbee D.E., Heederik D. Detection ofworkers sensitized to high molecular weight allergens: a diagnostic study in laboratory animal workers. Occup. Environ. Med. 2002; 59: 189–195.
147. Cullinan P., Tarlo S., Nemery B. The prevention of occupational asthma. Eur. Respir. J. 2003; 22: 853–860.
148. Gannon P.F., Berg A.S., Gayosso R. et al. Occupational asthma prevention and management in industry–an example of a global programme. Occup. Med. (Lond.) 2005; 55: 600–605.
149. Ruoppi P., Koistinen T., Susitaival P. et al. Frequency of allergic rhinitis to laboratory animals in university employees as confirmed by chamber challenges. Allergy 2004; 59: 295–301.
150. Kronqvist M., Johansson E., Pershagen G. et al. Increasing prevalence of asthma over 12 years among dairy farmers on Gotland, Sweden: storage mites remain dominant allergens. Clin. Exp. Allergy 1999; 29: 35–41.
151. Taiwo O.A., Sircar K.D., Slade M.D. et al. Incidence of asthma among aluminum workers. J. Occup. Environ. Med. 2006; 48: 275–282.
152. Meijer E., Suarthana E., Rooijackers J. et al. Application of a prediction model for work-related sensitisation in bakery workers. Eur. Respir. J. 2010; 36: 735–742.
153. Venables K.M., Dally M.B., Burge P.S. et al. Occupational asthma in a steel coating plant. Br. J. Industr. Med. 1985; 42: 517–524.
154. Grammer L.C., Shaughnessy M.A., Henderson J. et al. A clinical and immunologic study of workers with trimellitic-anhydrideinduced immunologic lung disease after transfer to low exposure jobs. Am. Rev. Respir. Dis. 1993; 148: 54–57.
155. Merget R., Caspari C., Dierkes'Globisch A. et al. Effectiveness of a medical surveillance program for the prevention of occupational asthma caused by platinum salts: a nested case-control study. J. Allergy Clin. Immunol. 2001; 107: 707–712.
156. Tarlo S.M., Liss G.M., Yeung K.S. Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures. Occup. Environ. Med. 2002; 59: 58–62.
157. Tarlo S.M., Liss G.M. Can medical surveillance measures improve the outcome of occupational asthma? J. Allergy Clin. Immunol. 2001; 107: 583–585.
158. Wild D.M., Redlich C.A., Paltiel A.D. Surveillance for isocyanate asthma: a model based cost effectiveness analysis. Occup. Environ. Med. 2005; 62: 743–749.
159. Suarthana E., Vergouwe Y., Nieuwenhuijsen M. et al. Diagnostic model for sensitization in workers exposed to occupational high molecular weight allergens. Am. J. Industr. Med. 2005; 48: 168–174.
160. Wilson J.M.G., Junger G. Principles and practice of screening for disease. Geneva, World Health Organization, 1968. Available from: http://whqlibdoc.who.int/php/WHO-PHP-34.pdf.
161. Heederik D., Henneberger P.K., Redlich C. Primary prevention: exposure reduction, skin exposure and respiratory protection. Eur. Respir. Rev. 2012 (in press).
162. Weeks J.L., Levy B.S., Wagner G.R. Preventing occupational disease and injury. Washington D.C., American Public Health Association; 1991.
163. Fisher R., Saunders W.B., Murray S.J. et al. Prevention of laboratory animal allergy. J. Occup. Environ. Med. 1998; 40: 609–613.
164. Goodno L.E., Stave G.M. Primary and secondary allergies to laboratory animals. J. Occup. Environ. Med. 2002; 44: 1143–1152.
165. Sjostedt L., Willers S., Orbaek P. et al. A seven-year followup study of lung function and methacholine responsiveness in sensitized and non-sensitized workers handling laboratory animals. J. Occup. Environ. Med. 1998; 40: 118–124.
166. Vanhanen M., Tuomi T., Tiikkainen U. et al. Risk of enzyme allergy in the detergent industry. Occup. Environ. Med. 2000; 57: 121–125.
167. Sorgdrager B., de Looff A.J., de Monchy J.G. et al. Occurrence of occupational asthma in aluminum potroom workers in relation to preventive measures. Int. Arch. Occup. Environ. Hlth 1998; 71: 53–59.
168. Petsonk E.L., Wang M.L., Lewis D.M. et al. Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 2000; 118: 1183–1193.
169. Fujita H., Sawada Y., Ogawa M. et al. [Health hazards from exposure to ortho-phthalaldehyde., a disinfectant for endoscopes., and preventive measures for health care workers]. Sangyo Eiseigaku Zasshi 2007; 49: 1–8.
170. Brisman J., Jarvholm B., Lillienberg L. Exposure-response relations for self reported asthma and rhinitis in bakers. Occup. Environ. Med. 2000; 57: 335–340.
171. Renstrom A., Mattsson M.L., Blidberg K. et al. Nasal air sampling for measuring inhaled wheat allergen in bakeries with and without facemask use. J. Occup. Environ. Med. 2006; 48: 948–954.
172. Liu Y., Stowe M.H., Bello D. et al. Respiratory protection from isocyanate exposure in the autobody repair and refinishing industry. J. Occup. Environ. Hyg. 2006; 3: 234–249.
173. Grammer L.C., Ditto A.M., Tripathi A. et al. Prevalence and onset of rhinitis and conjunctivitis in subjects with occupational asthma caused by trimellitic anhydride (TMA). J. Occup. Environ. Med. 2002; 44: 1179–1181.
174. Bateman E.D., Hurd S.S., Barnes P.J. et al. Global strategy for asthma management and prevention: GINA executive summary. Eur. Respir. J. 2008; 31: 143–178.
175. Beach J., Rowe B.H., Blitz S. et al. Diagnosis and management of work-related asthma. Evidence report/technology assessment (Summary) 2005; 1–8. Available from: www.ahrq.gov/clinic/epcsums/asthworksum.pdf
176. Newman Taylor A., Nicholson P.J., Cullinan P. et al. Guidelines for the prevention, identification, & management of occupational asthma: evidence review & recommendations. www.bohrf.org.uk/downloads/asthevre.pdf Date last updated: 2004. Date last accessed: January 16, 2012.
177. Henneberger P., Redlich C.A. Work-exacerbated asthma. In: Sigsgaard T., Heederik D., eds. Occupational asthma. Basel, BirkhaЁuser; 2010. 89–100.
178. Henneberger P.K., Redlich C.A., Callahan D.B. et al. An official American Thoracic Society statement: work-exacerbated asthma. Am. J. Respir. Crit. Care Med. 2011; 184: 368–378.
Для цитирования: Редакционная с. Бронхиальная астма и воздействие производственных факторов: клинические рекомендации Европейского респираторного общества. Пульмонология. 2012;(3):17-36.
For citation: . Bronchial asthma and exposure to occupational agents: clinical guidelines of European Respiratory Society. Russian Pulmonology. 2012;(3):17-36. (In Russ.)
- Обратные ссылки не определены.